Drug Type Small molecule drug |
Synonyms + [2] |
Target |
Mechanism HPV E1 inhibitors(HPV E1 inhibitors), HPV E2 inhibitors(HPV E2 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H36BrN3O4 |
InChIKeyIYWCUQWSZXLRNG-UHFFFAOYSA-N |
CAS Registry1075798-37-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Condylomata Acuminata | Phase 2 | - | - | |
Human Papillomavirus Infection | Phase 1 | FR | 28 Feb 2012 | |
Condylomata Acuminata | Phase 1 | FR | - | |
Condylomata Acuminata | Discovery | FR | - | |
Recurrent Respiratory Papillomatosis | Discovery | US | - |